Scratching the surface
Oppilotech’s model finds new targets for Gram-negative antibiotic potentiators
Oppilotech Ltd. is using computational modeling to develop first-in-class compounds that can permeate the lipopolysaccharide layer of the outer cell membrane of Gram-negative bacteria to potentiate existing antibiotics.
Marketed polymyxins are used to disrupt the lipopolysaccharide (LPS) to treat Gram-negative infections, but they have neurotoxic and nephrotoxic side effects that limit use to last resort cases.
“What polymyxins do is more like